Person: Dr Ted Hewitt

Dr Ted Hewitt

Dr Ted Hewitt has been appointed executive VP at the Social Sciences and Humanities Research Council (SSHRC), replacing Carmen Charette who was appointed VP external relations at the Univ of Victoria earlier this year. Hewitt comes to SSHRC from Western Univ (formerly Univ of Western Ontario) where he was VP research and international relations until…

Dr Graham Carr

Dr Graham Carr has been appointed VP research and graduate studies at Concordia Univ, a position he has held on an interim basis since January. Carr will be responsible for maximizing research funding opportunities, strategic research goals development, and facilitating research and research creation as well as technology transfer and knowledge mobilization. He holds a…

Dr Kate Moran

Dr Kate Moran has been appointed president and CEO of Ocean Networks Canada (ONC), replacing founding president and CEO Dr Martin Taylor. ONC was established in 2007 to manage the NEPTUNE Canada and VENUS cabled ocean networks and subsequently its Centre for Enterprise and Management. Moran was previously appointed to the position of director of…

Dr James Orbinski

Dr James Orbinski has been appointed director of the Africa Initiative at the Centre for International Governance Innovation in Waterloo ON. The Africa Initiative seeks to deepen Africa’s capacity and knowledge in areas such as conflict resolution, energy, food, security, health, migration and global warming. He holds an undergraduate degree from Trent Univ, an MD…

Dr WE (Ted) Hewitt

Boost contract research in Canada’s universities
By Dr Ted Hewitt

The 2006 Survey of Intellectual Property Commercialization for the higher education sector was recently released by Statistics Canada.

Dr Thomas Parr

Dr Thomas Parr has been appointed chief scientific officer of Targanta Therapeutics Inc (formerly PhageTech Inc), a private biopharmaceutical firm developing new classes of antibiotics based on its work with phage genomics (bacterial viruses). Parr was formerly with Adaptive Therapeutics, VP R&D at Embiosis Pharmaceuticals and senior director of microbiology with Xenogen Corp. He holds…

Dr Daniel Podolsky

Dr Daniel Podolsky and Dr Roderick Flower have joined the board of directors of Calgary’s Antibe Therapeutics Inc, an early-stage developer of drugs for inflammatory and cardiovascular diseases. Dr Podolsky is a professor of medicine at Harvard Univ and chief of gastroenterology at Massachusetts General Hospital. He is regarded as a leading authority on inflammatory…

Dr Ted Hewitt

Dr Ted Hewitt has been appointed VP research at the Univ of Western Ontario, a position he has held in an acting capacity since November/04 (R$, October 12/04). Hewitt assumed the position while he was associate VP research and international relations, following the departure of Dr Nils Petersen who was appointed DG of the National…

Garold G. Breit

Garold G. Breit has been appointed executive director of technology transfer at the Univ of Manitoba. Breit will work closely with VP research Dr Joanne Keselman, and is responsible for the university’s commercialization activities. His started his career at Revlon in the areas of marketing and acquisitions, moving on to serve as president of four…

Dr Ronald Bond

Dr Ronald Bond has been appointed to the chair of the advisory board for the Canadian Research Knowledge Network (CRKN). Bond is provost and VP academic at the Univ of Calgary and a member of the steering committee for the faculty bargaining project of the Canadian Association of University Business Officers (CAUBO). He has a…